Cleared Traditional

K854039 - LASER ASO KIT

K854039 is the FDA 510(k) clearance for LASER ASO KIT by Behring Diagnostics, Inc.. It is a Class 1 Microbiology device (product code GTQ) cleared through the Traditional 510(k) pathway after a 26-day FDA review.

K854039 · Behring Diagnostics, Inc. · Microbiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Oct 1985
Decision
26d
Days
Class 1
Risk

K854039 is an FDA 510(k) clearance for the LASER ASO KIT. Classified as Antistreptolysin - Titer/streptolysin O Reagent (product code GTQ), Class I - General Controls.

Submitted by Behring Diagnostics, Inc. (La Jolla, US). The FDA issued a Cleared decision on October 28, 1985 after a review of 26 days - a notably fast clearance cycle.

This device falls under the Microbiology FDA review panel, regulated under 21 CFR 866.3720 - the FDA microbiology device framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Fast-track predicate clearance. Standard predicate reliance. The short review cycle indicates strong predicate alignment - the FDA found sufficient equivalence without extended technical review.

View all Behring Diagnostics, Inc. devices

Submission Details

510(k) Number K854039 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 02, 1985
Decision Date October 28, 1985
Days to Decision 26 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary -
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
76d faster than avg
Panel avg: 102d · This submission: 26d
Pathway characteristics
Predicate-based equivalence.

Device Classification

Product Code GTQ Antistreptolysin - Titer/streptolysin O Reagent
Device Class Class 1 - General Controls
CFR Regulation 21 CFR 866.3720
What this classification means

Class I devices are subject to general controls only and most are exempt from 510(k) premarket notification. They represent the lowest regulatory burden in the FDA device framework.

Regulatory Peers - GTQ Antistreptolysin - Titer/streptolysin O Reagent

All 18
Devices cleared under the same product code (GTQ) and FDA review panel - the closest regulatory comparables to K854039.
QM300 CONTROL G PACK
K910887 · Kallestad Diag, A Div. of Erbamont, Inc. · Jun 1991
RAPITEX(R) ASL NEW
K903854 · Behring Diagnostics, Inc. · Jan 1991
ASO-CUBE(TM)
K901371 · Difco Laboratories, Inc. · May 1990
ASO SLIDE EIKEN
K853276 · Syn-Kit, Inc. · Aug 1985
SERIMM SURE ASO-CHEK CONTROL SERUM
K842839 · Analytical Products, Inc. · Aug 1984
ASO SURE
K820785 · Analytical Products, Inc. · Apr 1982